Skip to content

Tubeless Percutaneous Nephrolithotomy Without Reverse Insertion of a Ureteral Catheter

A Comparative Study of Tubeless Percutaneous Nephrolithotomy With or Without Reverse Ureteral Catheter Insertion

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05574517
Enrollment
200
Registered
2022-10-10
Start date
2022-10-07
Completion date
2024-12-31
Last updated
2024-09-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Percutaneous Nephrolithotomy, Urinary Calculi

Keywords

Ureteral catheter, Without reverse insertion, Percutaneous nephrolithotomy, Tubeless, Urinary calculi

Brief summary

Percutaneous nephrolithotomy(PCNL) is a surgical method for upper urinary calculi. The advent of tubeless PCNL (without indwelling nephrostomy tube) has been proved to be safe and effective in reducing postoperative discomfort, shortening hospitalization time and reducing hospitalization costs. Traditional tubeless PCNL usually involves retrograde insertion of the ureteral catheter, which may cause many ureteral related surgical complications. However, there are few reports on tubeless PCNL without reverse ureteral catheter insertion. The goal of this study is to explore the safety and effectiveness of the tubeless PCNL without reverse ureteral catheter insertion.

Detailed description

This is a key clinical research project of the University of South China (No. USCKF201902K01). The goal of this study is to comparative the safety and clinical efficacy between the tubeless percutaneous nephrolithotomy without reverse insertion of a ureteral catheter and the traditional tubeless percutaneous nephrolithotomy with reverse insertion of a ureteral catheter in the treatment of upper urinary calculi, and to explore the former' applications. It is a prospective, randomized controlled single center study that is conducted for 2 years anticipatively. The clinic physician is responsible for patient recruitment and allocation and the application of computerized random-number generation. For random allocation, participants are given random numbers. Participants with odd numbers are assigned to experimental group, where they undergo tubeless PCNL without reverse insertion of a ureteral catheter. Participants with even numbers are assigned to control group and undergo tubeless PCNL with reverse insertion of a ureteral catheter. The doctors managing the operations accept participants and execute the surgical treatments. All participants sign clinical-trial informed consent and surgical informed consent during the preoperative conversation. Follow-up observation is conducted for 1 month after surgery. After completion of the study, we collect relevant clinical data from the participants. The primary and secondary outcomes are analyzed and compared between the two groups.

Interventions

PROCEDUREWithout reverse insertion of a ureteral catheter

Traditional tubeless percutaneous nephrolithotomy usually need retrograde ureteral catheter insertion. Our intervention is that the tubeless percutaneous nephrolithotomy is executed without reverse insertion of a ureteral catheter.

Sponsors

The First Affiliated Hospital of University of South China
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Masking description

A single-blind trial in which participants were unaware of the study group and the intervention.

Intervention model description

Participants are randomly assigned to an experimental or control group in parallel.

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Participants who met the the applications of PCNL surgery in the 2019 Chinese Guidelines for the Diagnosis and Treatment of Urological Diseases * Participants who agree to undergo tubeless PCNL * The participants' maximum diameter of the stone should be less than 3.5cm

Exclusion criteria

* Confirmation by computerized tomography (CT) images and blood biochemical indicators of infectious stones or complex staghorn stones * Obvious surgical contraindications, such as severe heart and lung insufficiency, abnormal coagulatory function * Previous PCNL or nephrolithotomy, presence of an indwelling ureteral stent or nephrostomy tube before surgery * Renal trauma or congenital malformation of the urinary system

Design outcomes

Primary

MeasureTime frameDescription
Incidence of ureteral stone streetDay 2 after the surgeryThe rate of ureteral stone street after surgery
Changes in renal bleeding after surgeryHour 3 after the surgeryPre- vs. post-operative difference in hemoglobin and hematocrit values
Changes of renal-function after surgeryHour 3 after the surgeryPreoperative and postoperative blood creatinine difference
Pain score after surgeryHour 3 after the surgeryAccording to the Visual Analogue Scale(VAS) to evaluate the score. Scores range from 0 to 10, where 0 represents no pain and 10 represents the highest pain.
Incidence of pneumothorax and hydrothoraxDay 2 after the surgeryThe rate of pneumothorax and hydrothorax after surgery
Changes of inflammatory indicators after surgeryHour 3 after the surgeryPre- vs. post-operative blood leukocyte counts and neutrophil-ratio difference

Secondary

MeasureTime frameDescription
Duration of hospital stayimmediately after the dischargeFrom the date of admission to the date of discharge.
Hospital costsimmediately after the dischargeThe cost from hospitalization to discharge.
Stone-free ratesDay 2 after the surgeryPreoperative and postoperative stone dimensions are compared by radiological assessment. Postoperative residual calculi \< 4 mm in diameter reflect complete removal of calculi (stone-free rate = 100%).
Duration of operationduring the procedureFrom the completion of anesthesia to the end of the suture incision.

Countries

China

Contacts

Primary ContactMingyong Li, MD
myli1123@126.com18175878363

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026